Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisKazem Rahimi, Takayoshi Ohkubo, Barry R. Davis et al.|The Lancet|2021Cited by 997
Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2Lesley A. Stevens, Andrew S. Levey, Christopher H. Schmid et al.|American Journal of Kidney Diseases|2010Cited by 599
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Tom Greene, Hocine Tighiouart et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
Diabetic Proteinuria Revisited: Updated Physiologic PerspectivesSamuel N. Heyman, Zaid Abassi, Itamar Raz et al.|Cells|2022Cited by 51